Stem Cell Injection for Healing Chronic
Rotator Cuff Tears in a Rat Model
Faster
healing of the repaired tendon may prevent early re-rupture and post operative
stiffness by allowing active use of the shoulder in a shorter period of time. There are multiple biologic treatment interventions being examined such
as bipolar radiofrequency energy (bRFE), and BMP2. Several allo/xenograft tissue
patches to augment cuff repairs have already been examined in animal models and
are under clinical investigation.
One
potential source of rotator cuff repair augmentation is the use of adult
mesenchymal stem cells (MSCs). Mesenchymal
stem cells are derived from bone marrows donations and have demonstrated an
ability to induce bone, tendon, cartilage and ligament tissue healing and
formation. Adult mesenchymal stem
cells are already in use within clinical trials for regeneration of knee
meniscus after a meniscectomy, in graft vs. host disease, for prevention of
cardiomyopathy after an acute myocardial infarction, and in Chron’s disease. There are no studies that have attempted to evaluate the use of stem
cells to enhance rotator cuff tear healing.
In
this study 72 athymic rats will undergo a surgical bilateral rotator cuff
incision at the tendon insertion with 2 mm resected. After 6 weeks each rat with under go a rotator cuff repair bilaterally. The rats will be randomly assigned to two groups. The left shoulder repairs will serve as the control within each rat. The right shoulders will be the study shoulders between the groups. 36 rats will receive a stem cell injection with a carrier post
operatively and 36 will not. Comparisons
between the right and left shoulder of the rats will provide bias of treatment
information.
12
rats in each group will be sacrificed at 4 weeks, 12 at 8 weeks, and 12 rats at 12 weeks. The
surgical site will be inspected after sacrifice for tendon healing,
inflammation, and character of the healed tendon. After inspection, the specimens will be wrapped in saline soaked guaze,
placed in two plastic bags, and frozen at -20 degrees Celsius for later
analysis.8 of the 12 in each group will undergo biomechanical testing. 4 in each group will undergo histology blindly read by two different
pathologists.
Data
analysis will be evaluated using SPSS v 11.5 software. Descriptive statistics including frequencies, mean, standard deviation,
minimum and maximum values will be calculated. Analysis with student t-tests will be used for comparison of means
between groups. Chi squared analysis
will be used for nominal data. Results
will considered statistically significant when p< 0.05.